MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept DIO Ratio 2011-2026 | VERO
Annual DIO Ratio Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 361 | 354 | 242 | 222 | 243 | 204 | 162 | 82.9 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 361 | 82.9 | 234 |
Quarterly DIO Ratio Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 291 | 244 | 328 | - | 347 | 393 | 345 | - | 389 | 355 | 311 | - | 260 | 242 | 221 | - | 256 | 242 | 221 | - | 226 | 318 | 319 | - | 233 | 222 | 274 | - | 189 | 200 | 119 | - | 102 | 72.2 | 81.2 | - | 52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 393 | 52 | 245 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
20.2 | $ 10.42 | - | $ 1.41 B |  USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
Butterfly Network
BFLY
|
790 | $ 3.91 | - | $ 828 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
CONMED Corporation
CNMD
|
205 | $ 37.41 | - | $ 1.16 B | USA |
 |
Alphatec Holdings
ATEC
|
271 | $ 12.6 | - | $ 1.89 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 8.38 | - | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
146 | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 69.79 | - | $ 103 B | USA |
 |
Establishment Labs Holdings
ESTA
|
463 | $ 63.48 | - | $ 1.88 B |  Costa-rica |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
327 | $ 2.19 | - | $ 1.33 M | USA |
 |
Cytosorbents Corporation
CTSO
|
106 | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
125 | $ 1.33 | - | $ 21.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
220 | $ 11.03 | - | $ 298 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | Israel |
 |
LivaNova PLC
LIVN
|
127 | $ 61.43 | - | $ 3.35 B |  Britain |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
307 | $ 13.43 | - | $ 868 M | Israel |
 |
MiMedx Group
MDXG
|
123 | $ 4.41 | - | $ 652 M | USA |
 |
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | USA |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
32.1 | $ 2.59 | - | $ 152 M | Israel |
 |
Abbott Laboratories
ABT
|
120 | $ 109.95 | - | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
266 | $ 9.81 | - | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
237 | $ 261.24 | - | $ 7.37 B | USA |
 |
Insulet Corporation
PODD
|
210 | $ 224.66 | - | $ 15.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 9.01 | - | $ 694 M | USA |
 |
AxoGen
AXGN
|
238 | $ 32.84 | - | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
83.8 | $ 169.45 | - | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
216 | $ 32.76 | - | $ 4.88 K | USA |
 |
AVITA Medical
RCEL
|
202 | $ 4.62 | 5.0 % | $ 129 M |  Australia |